United States Dermatology Drug Market Report 2017

January 2018 | 105 pages | ID: U5439DC4475EN
QYResearch

Abstracts

In this report, the United States Dermatology Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Dermatology Drug in these regions, from 2012 to 2022 (forecast).

United States Dermatology Drug market competition by top manufacturers/players, with Dermatology Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• AbbVie
• Johnson & Johnson
• Bayer
• Galderma
• Bristol-Myers Squibb
• Novartis
• Pfizer
• Merz Pharma
• Valeant
• LEO Pharma
• GlaxoSmithKline

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• External Use
• Oral
• Injection

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Psoriasis
• Skin Infections
• Acne
• Dermatitis
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Dermatology Drug Market Report 2017

1 DERMATOLOGY DRUG OVERVIEW

1.1 Product Overview and Scope of Dermatology Drug
1.2 Classification of Dermatology Drug by Product Category
  1.2.1 United States Dermatology Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Dermatology Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 External Use
  1.2.4 Oral
  1.2.5 Injection
1.3 United States Dermatology Drug Market by Application/End Users
  1.3.1 United States Dermatology Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Psoriasis
  1.3.3 Skin Infections
  1.3.4 Acne
  1.3.5 Dermatitis
  1.3.6 Other
1.4 United States Dermatology Drug Market by Region
  1.4.1 United States Dermatology Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Dermatology Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Dermatology Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Dermatology Drug Status and Prospect (2012-2022)
  1.4.5 New England Dermatology Drug Status and Prospect (2012-2022)
  1.4.6 The South Dermatology Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Dermatology Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Dermatology Drug (2012-2022)
  1.5.1 United States Dermatology Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Dermatology Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES DERMATOLOGY DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Dermatology Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Dermatology Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Dermatology Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Dermatology Drug Market Competitive Situation and Trends
  2.4.1 United States Dermatology Drug Market Concentration Rate
  2.4.2 United States Dermatology Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Dermatology Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES DERMATOLOGY DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Dermatology Drug Sales and Market Share by Region (2012-2017)
3.2 United States Dermatology Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Dermatology Drug Price by Region (2012-2017)

4 UNITED STATES DERMATOLOGY DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Dermatology Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Dermatology Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Dermatology Drug Price by Type (2012-2017)
4.4 United States Dermatology Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES DERMATOLOGY DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Dermatology Drug Sales and Market Share by Application (2012-2017)
5.2 United States Dermatology Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES DERMATOLOGY DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AbbVie
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Dermatology Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AbbVie Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
  6.2.2 Dermatology Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Johnson & Johnson Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bayer
  6.3.2 Dermatology Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bayer Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Galderma
  6.4.2 Dermatology Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Galderma Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb
  6.5.2 Dermatology Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bristol-Myers Squibb Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Novartis
  6.6.2 Dermatology Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novartis Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Pfizer
  6.7.2 Dermatology Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pfizer Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Merz Pharma
  6.8.2 Dermatology Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Merz Pharma Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Valeant
  6.9.2 Dermatology Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Valeant Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 LEO Pharma
  6.10.2 Dermatology Drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 LEO Pharma Dermatology Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 GlaxoSmithKline

7 DERMATOLOGY DRUG MANUFACTURING COST ANALYSIS

7.1 Dermatology Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Dermatology Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Dermatology Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Dermatology Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES DERMATOLOGY DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Dermatology Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Dermatology Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Dermatology Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Dermatology Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Dermatology Drug
Figure United States Dermatology Drug Market Size (MT) by Type (2012-2022)
Figure United States Dermatology Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure External Use Product Picture
Figure Oral Product Picture
Figure Injection Product Picture
Figure United States Dermatology Drug Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Dermatology Drug by Application in 2016
Figure Psoriasis Examples
Table Key Downstream Customer in Psoriasis
Figure Skin Infections Examples
Table Key Downstream Customer in Skin Infections
Figure Acne Examples
Table Key Downstream Customer in Acne
Figure Dermatitis Examples
Table Key Downstream Customer in Dermatitis
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Dermatology Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Dermatology Drug Sales (MT) and Growth Rate (2012-2022)
Figure United States Dermatology Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Dermatology Drug Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Dermatology Drug Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Dermatology Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Dermatology Drug Sales Share by Players/Suppliers
Figure 2017 United States Dermatology Drug Sales Share by Players/Suppliers
Figure United States Dermatology Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Dermatology Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Dermatology Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Dermatology Drug Revenue Share by Players/Suppliers
Figure 2017 United States Dermatology Drug Revenue Share by Players/Suppliers
Table United States Market Dermatology Drug Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Dermatology Drug Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Dermatology Drug Market Share of Top 3 Players/Suppliers
Figure United States Dermatology Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Dermatology Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Dermatology Drug Product Category
Table United States Dermatology Drug Sales (MT) by Region (2012-2017)
Table United States Dermatology Drug Sales Share by Region (2012-2017)
Figure United States Dermatology Drug Sales Share by Region (2012-2017)
Figure United States Dermatology Drug Sales Market Share by Region in 2016
Table United States Dermatology Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Dermatology Drug Revenue Share by Region (2012-2017)
Figure United States Dermatology Drug Revenue Market Share by Region (2012-2017)
Figure United States Dermatology Drug Revenue Market Share by Region in 2016
Table United States Dermatology Drug Price (USD/Kg) by Region (2012-2017)
Table United States Dermatology Drug Sales (MT) by Type (2012-2017)
Table United States Dermatology Drug Sales Share by Type (2012-2017)
Figure United States Dermatology Drug Sales Share by Type (2012-2017)
Figure United States Dermatology Drug Sales Market Share by Type in 2016
Table United States Dermatology Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Dermatology Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Dermatology Drug by Type (2012-2017)
Figure Revenue Market Share of Dermatology Drug by Type in 2016
Table United States Dermatology Drug Price (USD/Kg) by Types (2012-2017)
Figure United States Dermatology Drug Sales Growth Rate by Type (2012-2017)
Table United States Dermatology Drug Sales (MT) by Application (2012-2017)
Table United States Dermatology Drug Sales Market Share by Application (2012-2017)
Figure United States Dermatology Drug Sales Market Share by Application (2012-2017)
Figure United States Dermatology Drug Sales Market Share by Application in 2016
Table United States Dermatology Drug Sales Growth Rate by Application (2012-2017)
Figure United States Dermatology Drug Sales Growth Rate by Application (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure AbbVie Dermatology Drug Sales Growth Rate (2012-2017)
Figure AbbVie Dermatology Drug Sales Market Share in United States (2012-2017)
Figure AbbVie Dermatology Drug Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Johnson & Johnson Dermatology Drug Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Dermatology Drug Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Dermatology Drug Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bayer Dermatology Drug Sales Growth Rate (2012-2017)
Figure Bayer Dermatology Drug Sales Market Share in United States (2012-2017)
Figure Bayer Dermatology Drug Revenue Market Share in United States (2012-2017)
Table Galderma Basic Information List
Table Galderma Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Galderma Dermatology Drug Sales Growth Rate (2012-2017)
Figure Galderma Dermatology Drug Sales Market Share in United States (2012-2017)
Figure Galderma Dermatology Drug Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Dermatology Drug Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Dermatology Drug Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Dermatology Drug Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis Dermatology Drug Sales Growth Rate (2012-2017)
Figure Novartis Dermatology Drug Sales Market Share in United States (2012-2017)
Figure Novartis Dermatology Drug Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer Dermatology Drug Sales Growth Rate (2012-2017)
Figure Pfizer Dermatology Drug Sales Market Share in United States (2012-2017)
Figure Pfizer Dermatology Drug Revenue Market Share in United States (2012-2017)
Table Merz Pharma Basic Information List
Table Merz Pharma Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Merz Pharma Dermatology Drug Sales Growth Rate (2012-2017)
Figure Merz Pharma Dermatology Drug Sales Market Share in United States (2012-2017)
Figure Merz Pharma Dermatology Drug Revenue Market Share in United States (2012-2017)
Table Valeant Basic Information List
Table Valeant Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Valeant Dermatology Drug Sales Growth Rate (2012-2017)
Figure Valeant Dermatology Drug Sales Market Share in United States (2012-2017)
Figure Valeant Dermatology Drug Revenue Market Share in United States (2012-2017)
Table LEO Pharma Basic Information List
Table LEO Pharma Dermatology Drug Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure LEO Pharma Dermatology Drug Sales Growth Rate (2012-2017)
Figure LEO Pharma Dermatology Drug Sales Market Share in United States (2012-2017)
Figure LEO Pharma Dermatology Drug Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Dermatology Drug
Figure Manufacturing Process Analysis of Dermatology Drug
Figure Dermatology Drug Industrial Chain Analysis
Table Raw Materials Sources of Dermatology Drug Major Players/Suppliers in 2016
Table Major Buyers of Dermatology Drug
Table Distributors/Traders List
Figure United States Dermatology Drug Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Dermatology Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Dermatology Drug Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Dermatology Drug Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Dermatology Drug Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Dermatology Drug Sales Volume (MT) Forecast by Type in 2022
Table United States Dermatology Drug Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Dermatology Drug Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Dermatology Drug Sales Volume (MT) Forecast by Application in 2022
Table United States Dermatology Drug Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Dermatology Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Dermatology Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Dermatology Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources